Sign in

CIK 0001557746

  • Non-accelerated filer
  • Smaller reporting company

Aclaris Therapeutics, Inc.

Sign in to watch
Ticker
ACRS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
460571712
Phone
+1 484-324-7933
Business address
701 LEE ROAD, SUITE 103, WAYNE, PA, 19087
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2015-10-13 Tullman Stephen A. Director Conversion · Series B Preferred Stock −31,913 0
2015-10-13 Tullman Stephen A. Director Conversion · Series C Preferred Stock −17,437 0
2015-10-08 RA CAPITAL MANAGEMENT, LLC 10% owner Purchase +21,691 $11.00 $239K 2,237,130
2015-10-07 RA CAPITAL MANAGEMENT, LLC 10% owner Purchase +938,041 $10.66 $10.0M 938,041
2015-10-07 RA CAPITAL MANAGEMENT, LLC 10% owner Purchase +1,250,000 $11.00 $13.8M 2,188,041
2015-10-07 RA CAPITAL MANAGEMENT, LLC 10% owner Purchase +27,398 $11.00 $301K 2,215,439
2015-10-07 VIVO VENTURES VII, LLC 10% owner Purchase +13,067 $11.00 $144K 296,739
2015-10-07 VIVO VENTURES VII, LLC 10% owner Purchase +285 $11.00 $3K 6,467
2015-10-07 CHA ALBERT Director Purchase +13,352 $11.00 $147K 303,206
2015-10-06 Bierly Rick Director Grant or award · Stock Option (right to buy) +17,800 17,800

Page 57 of 57 · 1,130 trades